Tempo Bioscience Services

Disease Models and Assay Services

Tempo Bioscience Services

Disease Models and Assay Services

Tempo Bioscience (Tempo) develops cutting-edge 2D&3D human cellular technologies to serve the needs of a variety of preclinical research & drug development pipelines across unique and diverse therapeutic and diagnostic areas. Tempo offers services and alliances based on our advanced technological platforms and a range of capabilities. Our team differentiates ourselves based on a strong commitment to innovative solutions and quality R&D for our partners.


Stem cell biobanking and biomarker development.


Tailored live-cell imaging and biosensor assay development


Patient relevant stem cell (iPSCs) based models to support drug discovery, preclinical studies, and early-stage clinical development.

3D Spheroid and Organoid model development.

Please contact Tempo Bioscience Support Team to receive a PDF copy of:

  • Biosensors-based stem cell models for drug discovery focusing on rare seizure disorders Cell Symposia 2016
  • Biosensors for Research & Drug Discovery SLAS2015
  • iPSC models to improve efficiency of drug discovery and development IPI (Summer 2018 Volume 10 Issue 2)
  • Human iPSC based Cell models for drug discovery and preclinical development CHI’s World Preclinical Congress Europe 2018
  • Human iPSC based cell models improve efficiency of drug discovery and development Pharma R&D Week 2021
X